Barclays
BRSH

Barclays’s Bruush Oral Care Inc. Common Stock BRSH Stock Holding History

Barclays’s Portfolio BRSH Stock Details BRSH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-9
Closed – – 5419
2022
Q3 		$0 Buy
+9
New +$381 ﹤0.01% 5219

Other funds holding BRSH

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
SC
Scotia Capital Toronto, Ontario, Canada $24.3B AUM 29.21% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays's BRSH Position: Q4 2022 in Review

Barclays sold out of Bruush Oral Care Inc. Common Stock (BRSH) in Q4 2022, closing a stake of 9 shares.

Barclays first reported a position in BRSH in Q3 2022 and held it in 1 quarter. The position peaked at $0 in Q3 2022. 5 funds tracked by Wall St. Rank hold BRSH as of Q4 2022.

  • Barclays reported no remaining Bruush Oral Care Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Barclays sold 9 Bruush Oral Care Inc. Common Stock shares in Q4 2022.
  • Barclays first reported a position in Bruush Oral Care Inc. Common Stock in Q3 2022 and held it in 1 quarter.
  • Barclays's Bruush Oral Care Inc. Common Stock position peaked at $0 in Q3 2022.
  • 5 funds tracked by Wall St. Rank held Bruush Oral Care Inc. Common Stock as of Q4 2022.

Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.